Table 5.
Short-term outcomes of patients undergoing transcatheter mitral valve implantation in mitral annular calcification
| Patient No. | Postoperative NYHA functional status at 12-mo clinic follow-up | 1-y mortality | Current status | Duration of survival | Cause of death |
|---|---|---|---|---|---|
| 1 | II | No | Dead | 24 mo | Right heart failure and end-stage renal failure |
| 2 | II | No | Alive | >12 mo | – |
| 3 | – | – | Dead | 2 d | Fixed cardiac output due to advanced rheumatic disease; LVOT obstruction, multiorgan failure |
| 4 | – | Yes | Dead | 2 mo | End-stage heart failure∗ |
| 5 | I | No | Alive | >12 mo | – |
| 6 | I | No | Alive | >12 mo | – |
| 7 | II | No | Alive | >12 mo | – |
| 8 | II | No | Alive | 4 mo |
NYHA, New York Heart Association; LVOT, left ventricular outflow tract.
∗
Preoperative pulmonary arterial pressure 105 mm Hg.